Cart
sales@molnova.com
Sophoraflavanone G
CAS No. 97938-30-2
Sophoraflavanone G ( Kushenol F;Vexibinol )
Catalog No. M21472 CAS No. 97938-30-2
Sophoraflavanone G (Kushenol F) isolated from Sophora flavescens induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 86 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 287 | In Stock |
|
| 50MG | 430 | In Stock |
|
| 100MG | 618 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSophoraflavanone G
-
NoteResearch use only not for human use.
-
Brief DescriptionSophoraflavanone G (Kushenol F) isolated from Sophora flavescens induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways.
-
DescriptionSophoraflavanone G (Kushenol F) isolated from Sophora flavescens induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways.
-
SynonymsKushenol F;Vexibinol
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number97938-30-2
-
Formula Weight424.5
-
Molecular FormulaC25H28O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)=CC[C@H](Cc(c(O[C@@H](CC1=O)c(ccc(O)c2)c2O)c1c(O)c1)c1O)C(C)=C
-
Chemical Name4H-1-Benzopyran-4-one 23-dihydro-57-dihydroxy-2-(24-dihydroxyphenyl)-8-(5-methyl-2-(1-methylethenyl)-4-hexenyl)- (S-(R*S*))-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li ZY et al. Sophoraflavanone G Induces Apoptosis in Human Leukemia Cells and Blocks MAPK Activation.Am J Chin Med. 2016;44(1):165-76.
molnova catalog
related products
-
ZZW-115 hydrochlorid...
ZZW-115 hydrochloride inhibits the activity of NUPR1.
-
Complanatoside
Complanatuside is a flavonoid found in the traditional Chinese medicine Semen Astragali Complanati.
-
Eriocalyxin B
Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways, should be considered a candidate for pancreatic cancer treatment.
